AI Tool Improves Prediction of Who Will Respond to Cancer Immunotherapy Drugs
hms.harvard.eduHarvard Medical School
A new AI tool enhances the ability to predict which cancer patients will respond to immunotherapy drugs, potentially improving treatment outcomes by identifying those most likely to benefit before therapy begins.
Why it mattersFor readers following AI applications in healthcare, this demonstrates how predictive models can reduce ineffective treatments and help oncologists make more informed therapy decisions for individual patients.
Read at hms.harvard.edu